PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-1.20%
Revenue decline while VET shows 7.95% growth. Joel Greenblatt would examine competitive position erosion.
-23.01%
Cost reduction while VET shows 3.55% growth. Joel Greenblatt would examine competitive advantage.
21.97%
Gross profit growth exceeding 1.5x VET's 8.85%. David Dodd would verify competitive advantages.
23.45%
Margin expansion exceeding 1.5x VET's 0.83%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.11%
Other expenses growth less than half of VET's 41.27%. David Dodd would verify if advantage is sustainable.
-0.35%
Operating expenses reduction while VET shows 12.09% growth. Joel Greenblatt would examine advantage.
-15.95%
Total costs reduction while VET shows 9.17% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-1.13%
D&A reduction while VET shows 9.00% growth. Joel Greenblatt would examine efficiency.
22.28%
EBITDA growth exceeding 1.5x VET's 7.51%. David Dodd would verify competitive advantages.
-17.93%
Both companies show margin pressure. Martin Whitman would check industry conditions.
42.63%
Operating income growth exceeding 1.5x VET's 6.76%. David Dodd would verify competitive advantages.
44.36%
Operating margin growth while VET declines. John Neff would investigate advantages.
80.01%
Other expenses growth above 1.5x VET's 5.17%. Michael Burry would check for concerning trends.
672.11%
Pre-tax income growth exceeding 1.5x VET's 87.60%. David Dodd would verify competitive advantages.
679.03%
Pre-tax margin growth exceeding 1.5x VET's 73.78%. David Dodd would verify competitive advantages.
556.64%
Tax expense growth above 1.5x VET's 172.05%. Michael Burry would check for concerning trends.
1968.89%
Net income growth exceeding 1.5x VET's 26.41%. David Dodd would verify competitive advantages.
1991.52%
Net margin growth exceeding 1.5x VET's 17.10%. David Dodd would verify competitive advantages.
2385.71%
EPS growth exceeding 1.5x VET's 23.26%. David Dodd would verify competitive advantages.
2450.00%
Diluted EPS growth exceeding 1.5x VET's 29.27%. David Dodd would verify competitive advantages.
-19.18%
Share count reduction while VET shows 0.87% change. Joel Greenblatt would examine strategy.
-18.90%
Diluted share reduction while VET shows 0.82% change. Joel Greenblatt would examine strategy.